1. Home
  2. FOXX vs CCEL Comparison

FOXX vs CCEL Comparison

Compare FOXX & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FOXX

Foxx Development Holdings Inc.

HOLD

Current Price

$3.55

Market Cap

35.6M

Sector

N/A

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.36

Market Cap

30.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXX
CCEL
Founded
2017
1989
Country
United States
United States
Employees
25
N/A
Industry
Managed Health Care
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.6M
30.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
FOXX
CCEL
Price
$3.55
$3.36
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
3.6M
9.0K
Earning Date
05-14-2026
04-14-2026
Dividend Yield
N/A
4.26%
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
N/A
$25,384,279.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$334.00
Revenue Growth
N/A
9.76
52 Week Low
$1.71
$2.72
52 Week High
$8.70
$5.43

Technical Indicators

Market Signals
Indicator
FOXX
CCEL
Relative Strength Index (RSI) 49.33 46.48
Support Level $2.69 $3.11
Resistance Level $4.88 $3.92
Average True Range (ATR) 0.38 0.29
MACD 0.06 -0.05
Stochastic Oscillator 80.29 38.26

Price Performance

Historical Comparison
FOXX
CCEL

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: